Pengaruh Infeksi Laten Toksoplasmosis Terhadap Lama Rawatan Skizofrenia Episode Pertama

Rina Amtarina, Andriza Andriza, Nurfi Pratiwi, Sarah Udayana

Abstract

Toxoplasma metabolism effect can rise the dopamine production which aggravate the simptoms of schizophrenia. Some of the research reports that patients which diagnosed with schizophrenia with positive IgG Toxoplasma need longer duration of treatment and may relapse. This study was conducted by cross sectional method on 51 patients with first episode schizophrenia, including acute and temporary psychotic disorder, in Tampan Mental Hospital – Pekanbaru. IgG anti-toxoplasma were detected on the patients at the first treatment in 2019, and then the length period of treatment and the recurrence frequency were monitored in the first year of the course of the disease. From the chi square test result, we can conclude that there’s no effect of IgG Toxoplasma on the duration of treatment on the first episode schizophrenia patients as well as the recurrence frequency which monitored in the first year course of the disease (p>0.05). There’s no effect of IgG Toxoplasma on the duration of treatment on the first episode schizophrenia patients as well as the recurrence frequency.

Keywords

Psychotic, Schizophrenia, Toxoplasma gondii, Toxoplasmosis

Full Text:

PDF

References

Holub D, Flegr J, Dragomirecka E, Rodriguez M, Preiss M, Novak T, Cermak J, Horacek J, Kodym P, Libiger J, Hoschl C, Motlova LB. Differences in onset of disease and severity of psychopathology between toxoplasma-sis-related and toxoplasmosis-unrelated schizophrenia. Acta Psychiatr. Scand. 2013; 127: 227-238.

Amir N. Skizofrenia dalam Buku Ajar Psikiatri. Badan Penerbit FKUI, Jakarta. 2010. Hal 170.

Sadock BJ, Sadock VA. Schizophrenia. In: Kaplan & Sadock’s: Sinopsis of Psychiatry. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 476.

Tamminga CA. Schizophrenia and Other Psychotic Disorders. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock’s: Comprehensive textbook of psychiatry. Vol 1. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 1432-1437.

Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behavior disorders – overview of evidence and mechanisms. Folia Parasitol. 2010; 57: 105-113.

Flegr, J. Influence of latent toxoplasmosis on the phenotype of intermediate hosts. Folia Parasitol. 2010: 57: 81-87.

Retmanasari A, Widartono BS, Wijayanti MA, Artama WT. Prevalence and risk factors for toxoplasmosis in Middle Java, Indonesia. Ecohealth. 2017 Mar 1; 14(1): 162-70

Khademvatan S, Saki J, Khajeddin N, Izadi-Mazidi M, Beladi R, Shafiee B et al. Toxoplasma gondii exposure and the risk of schizophrenia. Jundishapur J Microbiol. 2014; 7(11) : e12776.

Daryani A, Sharif M, Hosseini SH, Karimi SA, Gholami S. Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Tropical Biomedicine. 2010; 27(3): 476-482.

Horacek J, Flegr J, Tintera J, Verebova K, Spaniel F, Novak T, Brunovsky M, Bubenikova-Valesova V, Holub D, Palenicek T, Hoschl C. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J. Biol. Psychiatry. 2012; 13: 501-509.

Esshili A, Thabet S, Jemli A, Trifa F, Mechri A, Zaafrane F. Toxoplasma gondii infection in schizophrenia and associated clinical features. Elsevier. 2016;245:327-32. https://doi.org/10.1016/j.psychres.2016.08.056

Hamdani N, Daban-Huard C, Lajnef M, Richard JR, Delavest M, Godin O, et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013;148:444–8. http://dx.doi.org/10.1016/j. jad.2012.11.034

Celik T, Kartalci S, Aytas O, Akarsu GA, Gozukara H, Unal S. Association between latent toxoplasmosis and clinical course of schizophrenia – continues course of the disease is characteristic for Toxoplasma gondii infected patients. Folia Parasitol. 2015; 62: 015.

Celik T, Kaplan Y, Atas E, Oztuna D, Berilgen S. Toxocara seroprevalence in patients with idiophatic Parkinson’s disease: chance, association or coincidence? Biomed. Res. Int. 2013; 685196.

Goodwin DG, Strobl JS, Lindsay DS. Evaluation of five anti schizophrenic agents against Toxoplasma gondii in human cell cultures. J. Parasitol. 2011; 97: 148-151.

Flegr J. Schizophrenia and Toxoplasma gondii: an undervalued association?. Expert Review of Anti-Infective Therapy. 2015;13(7):817-20. https://doi.org/10.1586/14787210.2015.1051033

Flegr J, Prandota J, Sovickova M, Israili ZH. Toxoplasmosis - A global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9(3):e90203. https://doi.org/10.1371/journal.pone.0090203

DOI: https://doi.org/10.26891/JIK.v15i1.2021.21-25

Refbacks

  • There are currently no refbacks.